Dusty Tenney President, Brooks Life Sciences...Brooks Life Sciences at a Glance Key Metrics FY16...

Enhancing insights and speed of research with

market-leading sample management solutions

Dusty Tenney President, Brooks Life Sciences

Brooks Life Sciences – Agenda

2

Strong Markets

Key Strengths

Life Sciences Today

Growth Drivers

© 2018 Brooks Automation, Inc. • Proprietary Information

Brooks Life Sciences at a Glance

Key Metrics

FY16 FY17 1H18

Growth% 59% 38% 41%

# Employees 500 600 700

# Customers 600 800 1,100

# Acquisitions 0 3 2

% Brooks revenue 19% 21% 24%

23%

57%

20% Automated

Solutions

Consumables

& Instruments

Services/

Informatics

3

Part of Brooks growth engine

Revenue by Product Mix

2017


4

Key Developments Since Our Last Investor Day

On track to deliver $200M revenue in 2018

Delivering sustained, increasing profitability

Completed five acquisitions

Targeting 15% OP Margin* in 2019

4 * Non-GAAP financial measures – Projections exclude intangibles amortization, restructuring expense, and other special charges. © 2018 Brooks Automation, Inc. • Proprietary Information

$43

$68

$149

2013 2015 2017

-$8

-$17

$7

4%

-19%

-25%

Key Transition: Life Sciences Now Profitable

5

Revenue ($M)

Operating Margin* Operating Income* ($M)

2013 2015

2017 2017

36% CAGR

Profitable Growth

Transition to Profit

5

2013 2015

* Non-GAAP financial measures – see reconciliation tables. © 2018 Brooks Automation, Inc. • Proprietary Information

Consumables Instruments

20%

Automated

Solutions 23%

Services /

Informatics 57%

NA

63%

EU

35%

APAC

2%

Pharma

41%

Biotech

20%

Health- care /

Clinical

22%

Academic/ Govt 17%

Life Sciences’ Attractive Business Model

6 6

Recurring

Diverse Customer Base High Recurring Revenues Global Reach

38% Growth 53% Recurring Revenue 1,000 + Customers


2016 2017 2018 Est 2018 Target

Focus on Growth

7

Cross-selling initiatives

Highest quality samples

Outsourcing trend

Cold-chain automation

Emerging markets

ROIC discipline

Key Enablers $M

Life Sciences Organic Growth

200

108

+41

2021 model CAGR sustains high double-digit organic growth

+51

Organic

Acquisition


Building the Only One-Stop Comprehensive Sample Management Solution

How our acquisitions and partnerships fit into our vision

Solution Acquisitions Partnerships

Sample Storage

Media

Automation

Quality Archival

Storage

Complete Genomic

Analysis

Integrated

Informatics Suite

BioSpeciMan

8 © 2018 Brooks Automation, Inc. • Proprietary Information

http://www.bing.com/images/search?q=beckman+logo&id=0CE5AB9A77717C209FE171C46F3E59D6B863E598&FORM=IQFRBA

http://www.google.co.uk/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&uact=8&ved=0CAQQjRw&url=http://www.directindustry.com/prod/biocision/test-tube-storage-racks-54607-375328.html&ei=obHHVK63Kcm5ggTjhYG4Dg&bvm=bv.84349003,d.eXY&psig=AFQjCNFgAqnMr0aa58fqjOYLyZ5SkHI4Vg&ust=1422459681719402

http://www.google.com/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&uact=8&ved=0CAMQjRxqFQoTCMG35N3j8sgCFYR3PgodmIoD1w&url=http://www.launchpadinw.com/special-alert-brooks-automation-to-acquire-matrical-bioscience-for-10m/&psig=AFQjCNHpUt5oagBgrP8ZZuqL5e7EV9feXQ&ust=1446589437652868

http://www.biostorage.com/



Our Customers are the Leading Healthcare Organizations

1000+ leading healthcare companies depend on Brooks 9

Long-Standing Relationships New Strategic Relationships



10

Strong Markets

Key Strengths

Life Sciences Today

Growth Drivers


The Need for Samples Exploding

Market Trends Customer Needs

• Biologics

• Precision and

regenerative medicine

• Outsourcing

• Consumer genealogy

and genomics

• Digital technology

• High quality, annotated

samples

• Scientific services that

add value to assets

• Fully integrated

solutions

• Short and long-term

storage capability

• Informatics virtualize

and visualize

11

Pharma

41%

Biotech

20%

Healthcare/ Clinical

22%

Academic/ Government

17%

Customers


Positioned in a Large and Rapidly Growing Market

Other

• Translational

Samples

• Pathology

• API $1.7B

$2.5B

2017 2021

Growth in Sample Storage Addressable Market2 Breakdown of $7B1 Sample Storage Market

Cell Lines

Clinical Research Samples

Discovery Research

Compound Storage

Clinical Trials

Our share ~10% of $1.7B addressable market

~10% CAGR

Brooks growing at 2X market

12 1Total Addressable Market (TAM) - Market Research and Company Estimates

2Serviceable Addressable Market (SAM) – Market Research and Company Estimates © 2018 Brooks Automation, Inc. • Proprietary Information

Leading Positions in Large, Fragmented Market

Serviceable Addressable Market1 Differentiating Capabilities

Sample Management

• #1 provider of integrate sample storage and logistics

Scientific Services

• Leading provider of sample genomic analysis

Sample Informatics

• Defining the market to increase value of sample assets

Automation

• Market leader for compound and biological sample cold storage and retrieval

Consumables

• #2 provider of sample tubes, plates, and related instruments for cold storage automation

13

Services

and

Informatics

Automation

and

Sample Media

$1.1B

$0.6B

$1.7B

1Market Research and Company Estimates © 2018 Brooks Automation, Inc. • Proprietary Information

Well Positioned in Our Expanding End Markets

Pharma / Biotech Healthcare / Clinical Academic / Government Total

Market size1,2 $1.0B $0.5B $0.2B $1.7B

FY 17 Revenue $91M $33M $25M $149M

Market share 9% 7% 13% 9%

Revenue mix 61% 22% 17% 100%

Market growth1 10%

BRKS organic growth 27%

14 1Consultative Studies and Company Estimates 2SAM – Serviceable Addressable Market © 2018 Brooks Automation, Inc. • Proprietary Information


15

Strong Markets

Key Strengths

Life Sciences Today

Growth Drivers


Key Strengths We are Leveraging

16

Uniquely positioned in the industry 1

Large, growing, recurring revenue base 2

The advantage of scale 3


Comprehensive Sample Management Solution

Uniquely Positioned in the Industry

Consumables Automation High

Quality Archival Storage

Scientific / Lab

Services Informatics

Flexible Business

Model

Large Central Laboratories

Leading Life Science Company

17

1


How We Leverage Our Acquisitions to Cross Sell

18

Integrated solutions drives customer efficiency – cost and time

Research / Clinical Research Sample Workflow

Informatics Kit Transport Process Store Retrieve

1


65%

Total samples at customers’ sites managed by on-site Brooks personnel

Total customer samples in Brooks biorepositories

Percent of total samples collected remaining in storage1

Large and Growing Sample Collection Drives Recurring Revenue Base

19

Samples create sustainable annuity stream for Brooks

3M

32M

1Net of retrievals and destruction

2


Stored Samples Create Value-Add Opportunities and Strong Annuity

0

30

60

2015 2017 2021

Samples in Storage (Millions)

20

2015 2018 2021

Value-Add Opportunities (Average $ per sample)

• Storage

$1

$2

$4

• Sample Prep

• Relocation

• Storage

• Scientific Services

• Kitting

• Informatics

• Sample Prep

• Relocation

• Storage

2

32M samples today and growing © 2018 Brooks Automation, Inc. • Proprietary Information

3 The Advantages of Scale

21

No. of Stores and Storage Capacity Our Scale

• Over 150M samples stored in

Brooks automated stores

• Strong market positions for biologics,

tissues / cells and compounds

• Comprehensive sample

management solutions

for all of the top 20 Pharma

Over 60% market share in automated stores

220 235

250

280

325

88 113

125 135 150

FY13 FY14 FY15 FY16 FY17

# of Stores Total Sample Storage Capacity (M)



22

Strong Markets

Key Strengths

Life Sciences Today

Growth Drivers


Key Growth Drivers

23

Grow base

offerings through

existing customers

1

Expand solutions

throughout sample

management

workflows

2

Extend capabilities

into new markets

3


G R O W T H D R I V E R # 1

Share Gains Through Existing Customers

24

• Cryogenic automation platform expansion

• Unique and differentiating consumables, accessories and instruments

• Stores platform development

• Clinical ‘stockyard’

• Integrated bioinformatics solutions

Expanding, integrated portfolio has enabled share gains

Large Pharma Example

$2M $8M

$83M

$180M

FY17 FY21

21% CAGR

2018 2015



Expanding Range of Sample Management Solutions

25

Informatics Kit Transport Process Store Retrieve

Research / Clinical Research Sample Workflow

• Integrated ‘sample hub’ to provide full-range of storage and scientific services

• Cell line services and related cell therapy infrastructure and logistics

• Clinical study expansions

• Consumer market applications

$66M

$150M

FY17 FY21

23% CAGR

Integrated solutions drives customer value – cost and time © 2018 Brooks Automation, Inc. • Proprietary Information


Expanding Solutions to New Markets and Geographies

26

Significant investments underway in emerging markets

• Expand into clinical, cell therapy and personalized medicine

• Build out capabilities in Asia, especially China

• Expand network of direct and indirect sales channels

• Build BRAND recognition globally

$4M1

$20M1

FY17 FY21

50% CAGR

1Geographical overlay to previous revenue models © 2018 Brooks Automation, Inc. • Proprietary Information

Share gains and

innovation

Improved, higher

margin mix

Structural

optimization

Focused on

execution

2021 Target Model: Brooks Life Sciences Priorities

Life Sciences

FY17 FY21 Growth / Change

Revenue $149M $330M 22%

CAGR

Gross Margin* 38% 42-44% +4-6 pts

Operating

Margin* 4% ~20% ~16 pts

• BioStorage services

• Consumables

• Complete solutions

• Software, Cryo

• Increased sample value

• Material cost reductions

• Lean operations

• Sales team productivity

• Cross selling

• Strong leadership

• Strong markets

• Strong team

Strong markets, strong positions

27 * Non-GAAP financial measures – see reconciliation tables. Projections exclude intangibles amortization,

restructuring expense, and other special charges. © 2018 Brooks Automation, Inc. • Proprietary Information

I N S U M M A R Y

Outpacing the Market to Deliver Continued Strong Growth and Returns

28

Accelerated Growth • Investments positioned to sustain growth across the portfolio

=> Significantly outpacing underlying market growth

Recurring Revenues • Recurring revenue streams and strong backlog position

=> Provide confidence in future outlook

Doubling

Operating Profit

• Pathway to 20%+ Operating Profit* paved for FY21 => Starts with Q418 exit at 10%

Market Leader • Most comprehensive sample management solution in the market

=> 1st choice for top research companies


I N S U M M A R Y

Outpacing the Market to Deliver Continued Strong Growth and Returns

29

Accelerated Growth • Investments positioned to sustain growth across the portfolio

=> Significantly outpacing underlying market growth

Recurring Revenues • Recurring revenue streams and strong backlog position

=> Provide confidence in future outlook

Doubling

Operating Profit

• Pathway to 20%+ Operating Profit* paved for FY21 => Starts with Q4 FY18 exit at 10%

Market Leader • Most comprehensive sample management solution in the market

=> 1st choice for top research companies


Dusty Tenney President, Brooks Life Sciences...Brooks Life Sciences at a Glance Key Metrics FY16...

Documents

Transcript of Dusty Tenney President, Brooks Life Sciences...Brooks Life Sciences at a Glance Key Metrics FY16...